What Determines the Regulatory Requirements?
The applicable requirements are assessed using the manufacturer’s intended purpose, the device’s characteristics and the proposed activities in Saudi Arabia. A product name or photograph alone is insufficient to establish the appropriate regulatory approach.
The initial review considers:
- Intended purpose: the medical function described by the manufacturer, intended users and conditions of use.
- Device characteristics and risk classification: the technology, mode of operation and characteristics relevant to the applicable SFDA classification rules.
- Manufacturer and local arrangements: the legal manufacturer’s details and the roles of the proposed authorised representative, importer or distributor.
- Existing regulatory status: available Saudi authorisations, previous applications and any changes to the device or its documentation.
- Planned activity: initial market entry, continuation of an application, changes to an existing authorisation or coordination of a particular shipment.
The manufacturer is responsible for determining the device’s classification under SFDA rules. Motaded’s review identifies the documentation and support required for the proposed engagement.
Which Support Does Your Company Need?
The scope of support depends on the company’s role, the device’s regulatory status and the work already completed. The situations below provide a starting point for defining the engagement.
| Company situation | Relevant support | Motaded’s scope of work |
|---|---|---|
| An overseas manufacturer is preparing to enter the Saudi market | MDMA application preparation and authorised representative arrangements | Review available manufacturer and device documentation, identify outstanding materials and assist with the agreed application and representation arrangements. |
| A Saudi importer or distributor is preparing to supply medical devices | Regulatory documentation review and import coordination | Review available product authorisations, establishment documentation and shipment information; identify outstanding requirements and coordinate the agreed work. |
| A company has an existing or incomplete application | Application review and regulatory follow-up | Review submitted materials, SFDA correspondence and outstanding requests; prepare the agreed additions and coordinate authorised responses. |
| A company is planning changes to an authorised device or its documentation | Review of existing authorisation and proposed changes | Compare the proposed changes with available application records and identify the documentation and procedural support required. |
Application submission and follow-up are included where agreed and authorised. Support with authorised representative arrangements does not itself constitute Motaded’s appointment as the manufacturer’s authorised representative.
MDMA Application Support
Motaded assists with the preparation and coordination of Medical Devices Marketing Authorization (MDMA) applications. The engagement covers the agreed documentation review, application preparation and, where authorised, submission and regulatory follow-up.
Review of Device and Manufacturer Information
The initial review covers the device description, intended purpose, models and accessories, manufacturer details and available regulatory records. Existing applications and SFDA correspondence are reviewed where relevant.
The review identifies missing documents, inconsistent information and matters requiring clarification from the manufacturer.
Preparation of the Application Package
Available technical and administrative materials are organised for the agreed application. Device names, model references, manufacturer details and supporting documents are checked for consistency.
Outstanding technical evidence is requested from the manufacturer. Documentation review does not replace product testing, clinical evaluation or the manufacturer’s responsibility for the underlying evidence.
Submission and Regulatory Follow-up
Where included in the engagement, the application is submitted through the applicable SFDA channel following the necessary authorisation. Submission references and available confirmations are recorded.
During review, Motaded coordinates requests for additional information, obtains client or manufacturer input and prepares the agreed responses. Technical questions requiring manufacturer confirmation are referred to the responsible party.
Application Records and Deliverables
The client receives the agreed application materials, available submission confirmations and a record of regulatory correspondence. Progress updates identify completed work, outstanding requests and actions requiring client or manufacturer attention.
The engagement supports application preparation and follow-up. Assessment and the decision on marketing authorisation remain with SFDA.
Authorised Representation and Import Coordination
Authorised representation and import coordination are distinct services. They may be requested together or separately, according to the company’s role and the status of the device or consignment.
Authorised Representative Arrangements
For overseas manufacturers, Motaded reviews local representation arrangements and prepares the agreed mandate documentation.
The engagement identifies the appointed representative and each party’s responsibilities. It does not appoint Motaded as authorised representative; that appointment is established separately.
Medical Device Import Coordination
For planned or arrived consignments, Motaded reviews device authorisation records, importer documents and shipping information, then coordinates the agreed actions.
Customs declarations, freight, storage and third-party charges are included only where specified. Coordination does not guarantee clearance or release.
Request a Consultation
Motaded reviews the company’s role, the available device documentation and the status of any existing application or consignment. The written proposal defines the agreed support, deliverables and fee.
Technical Documentation Readiness
Application preparation begins with an inventory of available technical and administrative materials. The review records what has been supplied, identifies gaps and assigns requests to the client, manufacturer or appointed representative.
The groups below support the initial documentation review. The final document list is established for the device and proposed procedure.
| Document group | Materials for the initial review | Where gaps are addressed |
|---|---|---|
| Device identification and intended purpose | Product description, intended purpose, model list, configurations and relevant accessories | The manufacturer confirms the device information and supplies missing specifications. |
| Manufacturer and local party information | Legal manufacturer details, relevant company records and available representative or importer information | The manufacturer and relevant local parties provide or confirm their records. |
| Classification information | Proposed risk classification and the manufacturer’s supporting rationale | The manufacturer supplies or clarifies the classification rationale. |
| Quality and conformity documentation | Available quality management certificates, declarations of conformity and related supporting records | The manufacturer supplies current documents and clarifies their scope. |
| Safety and performance evidence | Available risk management records, test reports, performance evidence and clinical documentation, as applicable | The manufacturer provides the relevant evidence or arranges additional technical work. |
| Labelling and instructions for use | Current labels, packaging artwork and instructions for use for the proposed models | The manufacturer supplies controlled versions and confirms consistency with the device information. |
| Existing regulatory records | Previous MDMA records, application references, SFDA correspondence and outstanding requests | The client or appointed representative provides the available application history. |
Documentation Review Outcome
The review produces a documented list of available materials, missing items and required clarifications. Each outstanding item identifies the responsible party and the action needed before the agreed application work can proceed.
From Document Review to Application Outcome
Medical device application support involves coordinated work between the applicant, manufacturer and relevant local parties. The stages below describe an MDMA engagement; submission and follow-up are included where agreed and authorised.
-
Initial Review and Scope Confirmation
Responsible: Motaded and the client
The client provides device details, manufacturer information and available application records. Motaded reviews the materials, identifies outstanding information and defines the proposed work, deliverables and responsibilities.
-
Technical Documentation and Clarifications
Responsible: Manufacturer and client, coordinated by Motaded
The manufacturer supplies the relevant technical evidence and confirms device information. Motaded organises the documentation, checks consistency and records questions requiring clarification. The client coordinates access to manufacturer materials and relevant local-party records.
-
Application Preparation and Authorised Submission
Responsible: Motaded within the agreed scope; the authorised applicant confirms submission
Motaded prepares the agreed application package. The client and manufacturer confirm the accuracy of their supplied information and final document versions. Where submission is included, the application is submitted through the applicable channel under the appropriate authorisation, and available submission references are recorded.
-
Regulatory Review and Responses
SFDA assessmentResponsible: SFDA for assessment; applicant and manufacturer for responses, coordinated by Motaded
SFDA assesses the submitted application and may request additional information or clarification. Where follow-up is included, Motaded tracks requests and coordinates the agreed responses. Technical explanations and additional evidence are provided or confirmed by the manufacturer.
-
Decision, Records and Outstanding Actions
SFDA decisionResponsible: SFDA for the regulatory decision; Motaded for the agreed handover
The regulatory decision is issued by SFDA. Motaded communicates the available outcome and provides the agreed application records and correspondence, including authorisation documents where issued.
If further action is required, the handover identifies outstanding matters and the responsible parties. Where the engagement ends before a regulatory decision, the client receives the current application status and records of the completed work.
Fees and quotation
The quotation takes into account the required service, the product documentation and the status of any existing application.
Motaded service fee
- Charged for the agreed scope of work.
- Depends on the service and how ready the documents are.
- Confirmed in the written proposal before work begins.
Government and third-party charges
- Paid separately, if they apply.
- Depend on the specific procedure.
- Known costs at the time of the proposal are listed separately.
Confirm current government fees on the Authority’s published schedule.
Frequently Asked Questions
Is an Authorized Representative always required?
SFDA requires a licensed Saudi Authorized Representative for foreign manufacturers. Confirm the current rule on SFDA and on the Authorized Representative service page.
What is MDMA?
MDMA is the Medical Device Marketing Authorization issued by SFDA before a device is stored or sold in the Kingdom. Details are on the MDMA service page.
Can Motaded classify the device for SFDA?
SFDA decides the class. We review the information you provide and prepare the file on that basis. We do not replace the Authority’s classification.
Do you handle import as well as MDMA?
Yes, when it is included in the scope. Import work follows the customs clearance process and any SFDA or SABER evidence that applies.
How is Motaded’s price determined?
The fee depends on the applications included, the completeness of the file and whether representation is required. We confirm it in writing before work begins.